-
10006480-50The early stage of atherosclerosis is characterized by the aggregation of foam cells, so called a fatty streak, in the inner arterial wall. CAY10487 inhibits formation of fatty streak lesions of the thoracic aorta in high cholesterol-fed rabbits
-
10006480-500The early stage of atherosclerosis is characterized by the aggregation of foam cells, so called a fatty streak, in the inner arterial wall. CAY10487 inhibits formation of fatty streak lesions of the thoracic aorta in high cholesterol-fed rabbits
-
10007076-1CAY10491 is a synthetic intermediate useful for pharmaceutical synthesis.
-
10007076-100CAY10491 is a synthetic intermediate useful for pharmaceutical synthesis.
-
10007076-500CAY10491 is a synthetic intermediate useful for pharmaceutical synthesis.
-
10007077-1CAY10492 is a synthetic intermediate useful for pharmaceutical synthesis.
-
10007077-100CAY10492 is a synthetic intermediate useful for pharmaceutical synthesis.
-
10007077-5CAY10492 is a synthetic intermediate useful for pharmaceutical synthesis.
-
10007077-500CAY10492 is a synthetic intermediate useful for pharmaceutical synthesis.
-
10007078-1CAY10493 is a synthetic intermediate useful for pharmaceutical synthesis.
-
10007078-100CAY10493 is a synthetic intermediate useful for pharmaceutical synthesis.
-
10007078-500CAY10493 is a synthetic intermediate useful for pharmaceutical synthesis.